Weiss Multi-Strategy Advisers LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$142,000
-16.5%
15,051
-20.8%
0.00%
-20.0%
Q2 2020$170,000
+45.3%
18,992
+3.5%
0.01%0.0%
Q1 2020$117,000
-53.4%
18,344
-38.9%
0.01%
+25.0%
Q4 2019$251,000
-7.7%
30,0000.0%0.00%
-33.3%
Q3 2019$272,000
-15.8%
30,0000.0%0.01%
-33.3%
Q2 2019$323,000
+70.0%
30,000
+200.0%
0.01%
+50.0%
Q1 2018$190,000
-61.4%
10,000
-66.7%
0.01%
-53.8%
Q4 2017$492,000
-34.4%
30,000
-40.0%
0.01%
-53.6%
Q3 2017$750,000
+13.6%
50,000
-33.3%
0.03%0.0%
Q2 2017$660,000
+49.3%
75,000
-11.8%
0.03%
+55.6%
Q1 2017$442,000
+70.7%
85,0000.0%0.02%
+38.5%
Q4 2016$259,000
-34.3%
85,0000.0%0.01%
-45.8%
Q3 2016$394,000
+107.4%
85,000
+159.1%
0.02%
+60.0%
Q2 2016$190,000
-15.9%
32,805
+162.4%
0.02%
+200.0%
Q1 2014$226,000
+24.2%
12,500
-4.4%
0.01%
+25.0%
Q4 2013$182,00013,0700.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders